- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04423770
COVID-19 Related Health and Infection Control Practices Among Dentists
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- American Dental Association
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Primary dental practice is in United States
- 18 years of age or older
- Dentist
Exclusion Criteria:
•Answered "no" to ADA survey sent May 2020 that read "As part of ongoing efforts to monitor the effect of COVID-19 on the dental team, the ADA is interested in collecting data related to infection rates. Would you also be willing to participate in a separate, longitudinal study that would require you to report whether you or your staff have exhibited symptoms of COVID-19, and whether you have been tested or diagnosed? The study would be anonymous and under IRB protocols."
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
U.S. dentists
Dentists in the United States
|
No intervention; this is a purely observational study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
COVID-19 probable or confirmed case
Time Frame: 18 months
|
COVID-19 case as confirmed by clinician and/or detection of SARS-CoV-2 RNA or a specific antigen in a clinical specimen
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety
Time Frame: 12 months
|
Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4).
Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater anxiety.
|
12 months
|
Depression
Time Frame: 12 months
|
Assessed using the Patient Health Questionnaire for Depression and Anxiety (PHQ-4).
Two items scored 0 to 3 (total score of 0-6), with higher numbers indicating greater depressive symptoms.
|
12 months
|
Dental practice infection control efforts
Time Frame: 12 months
|
Self-reports of infection control efforts in the respondents' primary dental practices
|
12 months
|
Dentists' use of personal protective equipment
Time Frame: 12 months
|
Self-reports of personal protective equipment use
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cameron G Estrich, MPH, PhD, American Dental Association Science and Research Institute
Publications and helpful links
General Publications
- Eldridge LA, Estrich CG, Gurenlian JR, Battrell A, Lynch A, Vujicic M, Morrissey R, Dershewitz S, Geisinger ML, Araujo MWB. US dental health care workers' mental health during the COVID-19 pandemic. J Am Dent Assoc. 2022 Aug;153(8):740-749. doi: 10.1016/j.adaj.2022.02.011.
- Estrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, Araujo MWB. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020 Nov;151(11):815-824. doi: 10.1016/j.adaj.2020.09.005.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-08
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Acute Respiratory Syndrome Coronavirus 2
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
Oneness Biotech Co., Ltd.CompletedDisease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)United States
-
Saint Francis CareCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | CoronavirusUnited States
-
University Hospital, Basel, SwitzerlandCompletedSevere-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)Switzerland
-
ANRS, Emerging Infectious DiseasesRecruitingSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)France, Martinique
-
University of PecsHungarian Ministry of Innovation and TechnologyTerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Hungary
-
Cogna Technology Solutions LLCNovavaxCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)United Arab Emirates
-
Pulmoquine Therapeutics, IncRockefeller UniversityCompletedSevere Acute Respiratory Syndrome Coronavirus 2United States
-
Goethe UniversityNationwide Network of University Medicine (NUM) on Covid-19RecruitingSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Germany
-
AbbVieCompletedSevere Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)United States
Clinical Trials on No intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Wright State UniversityCompleted